One-Shot stem cell infusion tested to rescue brain after stroke
NCT ID NCT07371624
Summary
This early-stage study is testing the safety and early signs of effectiveness of a single intravenous infusion of donor-derived stem cells (called B2065) for people who have just had an ischemic stroke. The main goal is to see if the treatment is safe and well-tolerated when given within 36 hours of stroke symptoms starting. Researchers will also track whether participants show better recovery in movement, daily activities, and overall function over two years compared to those who receive a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tiantan Hospital, Capital Medical University
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.